Medix (331A) · InitiativeRestated
Growth Investment Funded by Acquisition Financing
First written in FY2026-H1. 1 of 2 entries say "Restated". Latest entry: FY2026.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Borrowing to Fund M&A and Growth InvestmentsA theme 83 companies write about · 3 as a headwind · 86 as a tailwind
6 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 83 companies compared. The sentences above are computed from all 83.Full recordFilings, disclosures and news, newest first
- FY2026RestatedAnnual report
「The Company resolved to borrow funds to acquire shares in 亞星通股份有限公司, entered into a monetary loan agreement as described below, and drew down the funds.」
The disclosure states that the Company entered into a 7-year borrowing agreement for ¥700,000 thousand to acquire 亞星通股份有限公司, with an outstanding balance of ¥649,900 thousand at the fiscal year-end. - FY2026-H1First statedAnnual report
「At a meeting of the Board of Directors held on 24 September 2025, the Company resolved to borrow funds to acquire shares in 亞星通股份有限公司, entered into a monetary loan agreement as described below, and drew down the funds.」
The Company borrowed ¥700 million to acquire shares in 亞星通股份有限公司, with a 7-year borrowing term.